Kai‐Tai Chang

716 total citations
20 papers, 560 citations indexed

About

Kai‐Tai Chang is a scholar working on Molecular Medicine, Pharmacology and Applied Microbiology and Biotechnology. According to data from OpenAlex, Kai‐Tai Chang has authored 20 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Medicine, 18 papers in Pharmacology and 6 papers in Applied Microbiology and Biotechnology. Recurrent topics in Kai‐Tai Chang's work include Antibiotic Resistance in Bacteria (19 papers), Antibiotics Pharmacokinetics and Efficacy (18 papers) and Antibiotic Use and Resistance (6 papers). Kai‐Tai Chang is often cited by papers focused on Antibiotic Resistance in Bacteria (19 papers), Antibiotics Pharmacokinetics and Efficacy (18 papers) and Antibiotic Use and Resistance (6 papers). Kai‐Tai Chang collaborates with scholars based in United States, Spain and Canada. Kai‐Tai Chang's co-authors include Vincent H. Tam, Kimberly R. Ledesma, Kamilia Abdelraouf, Kevin W. Garey, Henrietta Abodakpi, Song Gao, Michael Nikolaou, Jaye Weston, Ana María Sánchez‐Díaz and Rafael Cantón and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and Clinical Microbiology and Infection.

In The Last Decade

Kai‐Tai Chang

20 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kai‐Tai Chang United States 15 402 320 155 147 116 20 560
Concepción Segura Spain 10 442 1.1× 269 0.8× 183 1.2× 93 0.6× 93 0.8× 12 556
Henrietta Abodakpi United States 10 497 1.2× 353 1.1× 160 1.0× 193 1.3× 79 0.7× 12 563
Anna Vickers United Kingdom 15 512 1.3× 328 1.0× 199 1.3× 190 1.3× 146 1.3× 23 699
Justin R. Lenhard United States 16 527 1.3× 365 1.1× 174 1.1× 130 0.9× 172 1.5× 29 735
Anima Poudyal Australia 7 530 1.3× 329 1.0× 173 1.1× 76 0.5× 131 1.1× 10 634
Ken Coleman United States 9 331 0.8× 245 0.8× 151 1.0× 91 0.6× 79 0.7× 12 456
Panagiotis Poulikakos Greece 6 421 1.0× 199 0.6× 155 1.0× 116 0.8× 62 0.5× 8 529
Stephania Stump United States 9 321 0.8× 210 0.7× 109 0.7× 76 0.5× 128 1.1× 12 534
Evangelos Koratzanis Greece 6 416 1.0× 168 0.5× 156 1.0× 124 0.8× 62 0.5× 6 500
Liangfei Xu China 2 394 1.0× 150 0.5× 120 0.8× 143 1.0× 92 0.8× 4 484

Countries citing papers authored by Kai‐Tai Chang

Since Specialization
Citations

This map shows the geographic impact of Kai‐Tai Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai‐Tai Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai‐Tai Chang more than expected).

Fields of papers citing papers by Kai‐Tai Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai‐Tai Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai‐Tai Chang. The network helps show where Kai‐Tai Chang may publish in the future.

Co-authorship network of co-authors of Kai‐Tai Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Kai‐Tai Chang. A scholar is included among the top collaborators of Kai‐Tai Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai‐Tai Chang. Kai‐Tai Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abodakpi, Henrietta, et al.. (2019). A novel framework to compare the effectiveness of β-lactamase inhibitors against extended-spectrum β-lactamase-producing Enterobacteriaceae. Clinical Microbiology and Infection. 25(9). 1154.e9–1154.e14. 14 indexed citations
2.
Abodakpi, Henrietta, Kai‐Tai Chang, Song Gao, et al.. (2018). Optimal Piperacillin-Tazobactam Dosing Strategies against Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae. Antimicrobial Agents and Chemotherapy. 63(2). 27 indexed citations
3.
Tam, Vincent H., Kai‐Tai Chang, Jian Zhou, et al.. (2017). Determining β-lactam exposure threshold to suppress resistance development in Gram-negative bacteria. Journal of Antimicrobial Chemotherapy. 72(5). 1421–1428. 76 indexed citations
4.
Abodakpi, Henrietta, Kai‐Tai Chang, Ana María Sánchez‐Díaz, et al.. (2017). Prevalence of extended-spectrum beta-lactamase and carbapenemase-producing bloodstream isolates ofKlebsiella pneumoniaein a tertiary care hospital. Journal of Chemotherapy. 30(2). 115–119. 10 indexed citations
5.
Zhou, Jian, Kimberly R. Ledesma, Kai‐Tai Chang, et al.. (2017). Pharmacokinetics and Pharmacodynamics of Minocycline against Acinetobacter baumannii in a Neutropenic Murine Pneumonia Model. Antimicrobial Agents and Chemotherapy. 61(5). 27 indexed citations
6.
Abodakpi, Henrietta, Julia M. Gohlke, Kai‐Tai Chang, Diana S‐L Chow, & Vincent H. Tam. (2015). Analytical and Functional Determination of Polymyxin B Protein Binding in Serum. Antimicrobial Agents and Chemotherapy. 59(11). 7121–7123. 20 indexed citations
7.
Abdelraouf, Kamilia, Kai‐Tai Chang, Taijun Yin, Ming Hu, & Vincent H. Tam. (2014). Uptake of Polymyxin B into Renal Cells. Antimicrobial Agents and Chemotherapy. 58(7). 4200–4202. 47 indexed citations
8.
Hirsch, Elizabeth B., Kai‐Tai Chang, Paola Zucchi, et al.. (2013). An evaluation of multiple phenotypic screening methods for Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae. Journal of Infection and Chemotherapy. 20(3). 224–227. 10 indexed citations
9.
Tam, Vincent H., Kai‐Tai Chang, Zhen Yang, Joseph Newman, & Ming Hu. (2012). In Vitro Pharmacodynamics of AZD5206 against Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 57(2). 1062–1064. 5 indexed citations
10.
Singh, Renu, et al.. (2011). Modelling biphasic killing of fluoroquinolones: guiding optimal dosing regimen design. Journal of Antimicrobial Chemotherapy. 66(5). 1079–1086. 8 indexed citations
11.
Guo, Beining, Kamilia Abdelraouf, Kimberly R. Ledesma, et al.. (2011). Quantitative Impact of Neutrophils on Bacterial Clearance in a Murine Pneumonia Model. Antimicrobial Agents and Chemotherapy. 55(10). 4601–4605. 26 indexed citations
12.
Singh, Renu, Kimberly R. Ledesma, Kai‐Tai Chang, & Vincent H. Tam. (2010). Impact of recA on Levofloxacin Exposure-Related Resistance Development. Antimicrobial Agents and Chemotherapy. 54(10). 4262–4268. 21 indexed citations
13.
Chang, Kai‐Tai, et al.. (2010). Mathematical Modeling To Characterize the Inoculum Effect. Antimicrobial Agents and Chemotherapy. 54(11). 4739–4743. 13 indexed citations
14.
Tam, Vincent H., Kai‐Tai Chang, Kamilia Abdelraouf, et al.. (2010). Prevalence, Resistance Mechanisms, and Susceptibility of Multidrug-Resistant Bloodstream Isolates of Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 54(3). 1160–1164. 121 indexed citations
15.
Tam, Vincent H., et al.. (2009). Killing of Escherichia coli by β-lactams at different inocula. Diagnostic Microbiology and Infectious Disease. 64(2). 166–171. 15 indexed citations
16.
Singh, Renu, et al.. (2009). Pharmacodynamics of moxifloxacin against a high inoculum of Escherichia coli in an in vitro infection model. Journal of Antimicrobial Chemotherapy. 64(3). 556–562. 16 indexed citations
17.
Tam, Vincent H., et al.. (2009). Impact of AmpC overexpression on outcomes of patients with Pseudomonas aeruginosa bacteremia. Diagnostic Microbiology and Infectious Disease. 63(3). 279–285. 15 indexed citations
18.
Lim, Tze-Peng, Kimberly R. Ledesma, Kai‐Tai Chang, et al.. (2008). Quantitative Assessment of Combination Antimicrobial Therapy against Multidrug-Resistant Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy. 52(8). 2898–2904. 31 indexed citations
19.
Nikolaou, Michael, et al.. (2007). Modeling of Microbial Population Responses to Time-Periodic Concentrations of Antimicrobial Agents. Annals of Biomedical Engineering. 35(8). 1458–1470. 19 indexed citations
20.
Tam, Vincent H., Kai‐Tai Chang, Mark LaRocco, et al.. (2007). Prevalence, mechanisms, and risk factors of carbapenem resistance in bloodstream isolates of Pseudomonas aeruginosa. Diagnostic Microbiology and Infectious Disease. 58(3). 309–314. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Concepción Segura Breakdown of academic impact, for papers by Henrietta Abodakpi Breakdown of academic impact, for papers by Anna Vickers Breakdown of academic impact, for papers by Justin R. Lenhard Breakdown of academic impact, for papers by Anima Poudyal Breakdown of academic impact, for papers by Ken Coleman Breakdown of academic impact, for papers by Panagiotis Poulikakos Breakdown of academic impact, for papers by Stephania Stump Breakdown of academic impact, for papers by Evangelos Koratzanis Breakdown of academic impact, for papers by Liangfei Xu
Rankless by CCL
2026